Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein J2 (FOXJ2) is a transcriptional activator belonging to the forkhead box family of transcription factors, characterized by a conserved forkhead (winged-helix) DNA binding domain[1][2][3][6]. It binds to specific DNA sequences and regulates the expression of multiple genes, functioning as a regulator of biological processes such as angiogenesis and cell differentiation[1][6]. FOXJ2 plays an important role in tumorigenesis, progression, and metastasis of certain cancers—implicated, for example, in inhibition of breast cancer metastasis through regulation of EMT markers E-cadherin and vimentin[2][4]. In mice, FOXJ2 is required for the production of interferon-alpha by plasmacytoid dendritic cells, highlighting a potential role in immune regulation[5]. There are currently no widely reported small-molecule or biological drugs directly interacting with or targeting FOXJ2, nor are mechanisms of action, biomarkers, or safety concerns established for clinical targeting of FOXJ2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein J2 (FOXJ2).